Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Resting State Brain Entropy Alterations in Relapsing Remitting Multiple Sclerosis.
Transgenic inhibition of astroglial NF-kappaB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.
Alemtuzumab for multiple sclerosis: who and when to treat?
Regulation of myelination in the Central Nervous System by Nuclear Lamin B1 and non-coding RNAs.
Glutathione in multiple sclerosis: More than just an antioxidant?
Effects of Bacille Calmette-GuÉrin after the first demyelinating event in the CNS.
The role of mast cells in neuroinflammation.
An Increase in Tolerogenic Dendritic Cell and Natural Regulatory T Cell Numbers during Experimental Autoimmune Encephalomyelitis in Rras-/- Mice Results in Attenuated Disease.
Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis.
Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.
Cyclophosphamide so-so verdict in progressive MS
Perceived and actual arm performance in multiple sclerosis: relationship with clinical tests according to hand dominance.
MRI correlates of disability in african-americans with multiple sclerosis.
Clinical designs of recent robot rehabilitation trials.
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis.
Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.
Immunosuppressive treatments in multiple sclerosis.
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells.
Methods for the detection of peptidylarginine deiminase activity and protein citrullination.
GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions.
A facilitation and co-ordination therapy approach to the treatment of multiple sclerosis.
The Prevalence of Pain in Adults with Multiple Sclerosis: A Multicenter Cross-Sectional Survey.
Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.
Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies.
Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS.
Pages
« first
‹ previous
…
224
225
226
227
228
229
230
231
232
…
next ›
last »